Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation

被引:38
|
作者
Nakamura, Tsukasa [1 ]
Ushigome, Hidetaka [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kyoto 6028566, Japan
关键词
myeloid-derived suppressor cells; organ transplantation; tolerance; regulatory T cells; regulatory B cells; iNKT cells; regulatory dendritic cells; regulatory macrophages; CARDIAC ALLOGRAFT SURVIVAL; ARYL-HYDROCARBON RECEPTOR; COLONY-STIMULATING FACTOR; HEPATIC STELLATE CELLS; T-CELLS; DENDRITIC CELLS; NITRIC-OXIDE; B-CELLS; RENAL-TRANSPLANTATION; MOUSE MODEL;
D O I
10.3390/ijms19082357
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regulation of allo-immune responses is proposed as a topic for investigation in the current field of organ transplantation. As a regulator, regulatory T cells (Tregs) have received attention due to their ability to control allograft rejection. Concurrently, however, the independent action of Tregs is not enough to achieve tolerance status in many situations. Meanwhile, as a multi-functional regulator, myeloid-derived suppressor cells (MDSCs) can suppress effector T cells as well as induce Tregs or regulatory B cells (Bregs) in certain circumstances. Furthermore, the importance of a crosstalk between MDSCs and natural killer T cells to induce tolerance has been reported. Thus, orchestration between MDSCs, myeloid regulators, T/Bregs and other lymphoid/myeloid regulators can shed light on achieving allogeneic tolerance. Here, we review the current knowledge in terms of immunological regulatory function displayed by MDSCs in the context of organ transplantation. Ideal control of MDSCs would lead to a reduction of allograft rejection and subsequent long-term allograft acceptance.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Myeloid-derived suppressor cells in glioma
    Mirghorbani, Masoud
    Van Gool, Stefaan
    Rezaei, Nima
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1395 - 1406
  • [32] Myeloid-Derived Suppressor Cells and Radiotherapy
    Jimenez-Cortegana, Carlos
    Galassi, Claudia
    Klapp, Vanessa
    Gabrilovich, Dmitry, I
    Galluzzi, Lorenzo
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (05) : 545 - 557
  • [33] EBV and myeloid-derived suppressor cells
    Sinha, Debottam
    Khanna, Rajiv
    BLOOD, 2021, 137 (02) : 148 - 150
  • [34] Myeloid-derived suppressor cells in gliomas
    Gieryng, Anna
    Kaminska, Bozena
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (05): : 345 - 351
  • [35] Myeloid-Derived Suppressor Cells in Sepsis
    Lai, Dengming
    Qin, Chaojin
    Shu, Qiang
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [36] Defining myeloid-derived suppressor cells
    Akkari, Leila
    Amit, Ido
    Bronte, Vincenzo
    Fridlender, Zvi G.
    Gabrilovich, Dmitry I.
    Ginhoux, Florent
    Hedrick, Catherine C.
    Ostrand-Rosenberg, Suzanne
    NATURE REVIEWS IMMUNOLOGY, 2024, 24 (12) : 850 - 857
  • [37] Myeloid-derived Suppressor Cells in Sepsis
    van der Poll, Tom
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (03) : 256 - 258
  • [38] Therapeutic potential of monocytic myeloid-derived suppressor cells in islet transplantation
    Harada, Masaki
    Uchida, Koichiro
    Fujimoto, Keiichi
    Matsumoto, Ryu
    Tokushige, Koji
    Okumura, Ko
    Takeda, Kazuyoshi
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 17 - 18
  • [39] Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases
    Zhang, Jilu
    Hodges, Alan
    Chen, Shu-Hsia
    Pan, Ping-Ying
    CELLULAR IMMUNOLOGY, 2021, 362
  • [40] Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
    Koehn, Brent H.
    Blazar, Bruce R.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (02) : 335 - 341